Results 151 to 160 of about 28,653 (195)

A randomized sequential cross-over trial evaluating five purportedly ICP-lowering drugs in idiopathic intracranial hypertension. [PDF]

open access: yesHeadache
Mitchell JL   +10 more
europepmc   +1 more source

The Prevalence of Hypertension Among Children and Antihypertensive Use: Protocol for a Systematic Review and Meta-Analysis.

open access: yesJMIR Res Protoc
Maamor NH   +6 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Spironolactone in dermatology

Dermatologic Therapy, 2022
Spironolactone is a drug, similar in structure to aldosterone and acts as an aldosterone receptor antagonist with an anti-androgenic effect. This drug has proven to be useful in several dermatological entities, however its use has not been well explored.
Diana Alejandra, Aguilar Medina   +2 more
openaire   +2 more sources

Novel spironolactone-analogs as impurities in spironolactone

Steroids, 2004
Six novel spironolactone-analogs steroids (3-8) were isolated from spironolactone by using various chromatographic methods. Their structures were elucidated by spectrometric analysis. Two of the analogs (3 and 7) were confirmed by X-ray crystallography.
Xiao-Yi Wang   +3 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy